BCWM
SGMO

Bartlett & Co Wealth Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bartlett & Co Wealth Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-600
Closed -$3.49K – 1322
2022
Q1 		$3.49K Buy
+600
New +$3.57K ﹤0.01% 954

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bartlett & Co Wealth Management's SGMO Position: Q2 2022 in Review

Bartlett & Co Wealth Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2022, closing a stake of 600 shares — an estimated $3.49K sold.

Bartlett & Co Wealth Management first reported a position in SGMO in Q1 2022 and held it in 1 quarter. The position peaked at $3.49K in Q1 2022. 188 funds tracked by Wall St. Rank hold SGMO as of Q2 2022.

  • Bartlett & Co Wealth Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2022 after selling out during the quarter.
  • Bartlett & Co Wealth Management sold 600 SANGAMO THERAPEUTICS INC shares in Q2 2022, an estimated $3.49K.
  • Bartlett & Co Wealth Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2022 and held it in 1 quarter.
  • Bartlett & Co Wealth Management's SANGAMO THERAPEUTICS INC position peaked at $3.49K in Q1 2022.
  • 188 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2022.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2022, filed 14 Feb 2024.